BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody

Within the partnership, Toregem BioPharma will have access to WuXi Biologics' integrated CMC services in cell line development, cell banking and testing se...

October 12, 2022 | News

China NMPA Approves Selpercatinib for the Treatment of Patients with RET-driven Lung and Thyroid Cancers

Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality med...

October 10, 2022 | News

Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating XW014

Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic dis...

October 10, 2022 | News

Concord Medical Announces Changes in Management

Mr. Yaw Kong Yap has stepped down from his role as the chief financial officer and president of the Company due to reaching retirement age, effec...

October 03, 2022 | News

WuXi Biologics Topped Off the Steel on its Commercial Biomanufacturing Facility

WuXi Biologics ("WuXi Bio") (2269.HK), a global Contract Research, Development and Manufacturing Organization (CRDMO), held a topping-off ceremony, i...

September 29, 2022 | News

Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate

The investigational new drug (IND) application was submitted by Telix's partner in the Greater China region, Grand Pharmaceutical Group Limited (...

September 28, 2022 | News

Nippon Express (China) Participates in 11th Global Pharmaceutical Cold Chain Summit

More than 600 participants from about 300 companies, including pharmaceutical manufacturers and retailers as well as logistics companies that handle pharma...

September 27, 2022 | News

Antibiotics Markets in China: Demand to Grow by 9% by 2031

China's demand for Antibiotics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chine...

September 26, 2022 | News

Shandong Proton Center Celebrates Milestone in Delivering High-Quality Proton Treatment

Proton therapy can be used to treat many of the most common types of cancer. All radiotherapy, including proton and high energy X-rays (photon), destroys c...

September 26, 2022 | News

AAHRPP Accredits Five More Research Organizations, Including First in Japan

At its September meeting, AAHRPP's Council on Accreditation awarded full accreditation to: Adventist Health Glendale, Glendale, California, a hospi...

September 26, 2022 | News

DLA Piper attends signing ceremony for exclusive strategic collaboration with Beijing E-town

Beijing E-town Bio Park is located in Beijing Economic and Technological Development Zone and has attracted close to 200 prestigious life science enterpris...

September 13, 2022 | News

WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility

WuXi STA, a subsidiary of WuXi AppTec, today announced the opening of a new sterile lipid nanoparticle (LNP) formulation development and manufacturing faci...

September 12, 2022 | News

Jacobio Completes First Patient Dosage of CD73 mAb JAB-BX102 in China

This is a phase I/IIa multi-center, open-label clinical study to evaluate the safety, tolerability, pharmacokinetics, and preliminary evidence of anti-tumo...

September 05, 2022 | News

Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases

Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi t...

August 29, 2022 | News

Stay Connected